Overview

A Novel Combination Oral Agent to Treat Acne Vulgaris

Status:
Unknown status
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate a novel, combination product for the treatment of acne vulgaris in females
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Nexgen Dermatologics, Inc.
Treatments:
Doxycycline
Equol